Wikipedia

Template:Transdermal estradiol patches marketed in the United States

Available transdermal estradiol patches in the United States[1][2][a]
Brand name Dose
(µg/day) 		DOA (d) Size[b][c]
(cm2) 		Levels
(pg/mL) 		Intro.
Alora[3][4] 25, 50, 75, 100 3–4 9, 18, 27, 36 43–144 1996
Climara[d][5][6] 25, 37.5, 50,
60, 75, 100 		7 6.5, 9.375, 12.5,
15, 18.75, 25 		17–174 1994
Climara Pro[e][7][8] E2 (45)
LNGTooltip Levonorgestrel (15) 		7 22 27–54 2003
CombiPatch[e][9][10] E2 (50)
NETATooltip Norethisterone acetate (14, 25) 		3–4 9, 16 27–71 1998
Menostar[11][12] 14 7 3.25 13–21 2004
Minivelle[13][14] 25, 37.5, 50,
75, 100 		3–4 1.65, 2.48, 3.3,
4.95, 6.6 		30–117 2012
Vivelle[15][16] 50, 100 3–4 14.5, 29 30–145 2000
Vivelle-Dot[d][17][18] 25, 37.5, 50,
75, 100 		3–4 2.5, 3.75, 5,
7.5, 10 		30–145 1996
  1. ^ Specific links for each patch's FDA approval and label are not given.
  2. ^ For comparison, a United States quarter is about 4.6 cm2 (0.72 in2).
  3. ^ Sizes are respective to the dosages in the dose column.
  4. ^ a b Generic version available.
  5. ^ a b Combined with a progestin.

See also edit

References edit

  1. ^ Henzl MR, Loomba PK (July 2003). "Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice". J Reprod Med. 48 (7): 525–40. PMID 12953327.
  2. ^ "Drugs@FDA: FDA Approved Drug Products". United States Food and Drug Administration. Retrieved 26 July 2018.
  3. ^ "Alora (Estradiol Transdermal System, USP)". Drugs@FDA: FDA-Approved Drugs. U.S. Food and Drug Administration.
  4. ^ "Alora (Estradiol Transdermal System, USP)" (PDF). U.S. Food and Drug Administration.
  5. ^ "Drugs@FDA: FDA-Approved Drugs". U.S. Food and Drug Administration.
  6. ^ "Climara (estradiol transdermal system)" (PDF). U.S. Food and Drug Administration.
  7. ^ "Drugs@FDA: FDA-Approved Drugs".
  8. ^ "Climara Pro (estradiol/levonorgestrel transdermal system)" (PDF). U.S. Food and Drug Administration.
  9. ^ "Combipatch (estradiol, norethindrone acetate". Drugs@FDA: FDA-Approved Drugs. U.S. Food and Drug Administration.
  10. ^ "Prescribing Information: CombiPatch (estradiol/norethindrone acetate transdermal system)" (PDF). U.S. Food and Drug Administration.
  11. ^ "Menostar (estradiol)". Drugs@FDA: FDA-Approved Drugs. U.S. Food and Drug Administration.
  12. ^ "Highlight of Prescribing Information: Menostar (estradiol transdermal system)" (PDF). U.S. Food and Drug Administration.
  13. ^ "MINIVELLE (estradiol)". Drugs@FDA: FDA-Approved Drugs. U.S. Food and Drug Administration.
  14. ^ "MINIVELLE (estradiol transdermal system)" (PDF). U.S. Food and Drug Administration.
  15. ^ "VIVELLE (estradiol)". Drugs@FDA: FDA-Approved Drugs. U.S. Food and Drug Administration.
  16. ^ "Vivelle (estradiol transdermal system)" (PDF). U.S. Food and Drug Administration.
  17. ^ "Estradiol". Drugs@FDA: FDA-Approved Drugs. U.S. Food and Drug Administration.
  18. ^ "VIVELLE-DOT® (estradiol transdermal system)" (PDF). U.S. Food and Drug Administration.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Template:Transdermal_estradiol_patches_marketed_in_the_United_States&oldid=1009479725"